in this issue
Regions :: Southeast Asia :: Singapore
Reliance Buys Biotech Firm
10:16 AM MDT | July 30, 2007 | Chemical Week Editorial Staff
Reliance Life Sciences (RLS: Mumbai), part of the Reliance Group, says it will acquire a controlling stake in biopharmaceutical company GeneMedix (Newmarket, U.K.). RLS will invest â‚¤32.1 million ($62.7 million) in GeneMedix over the next five years, enabling RLS to launch its biosimilars in Europe and the U.S. GeneMedix has operations in Europe, and stock exchange listings in London and Singapore. RLS’s investment will be made in two segments. An initial investment of approximately â‚¤14.6 million will be made for the purchase of 1.16 billion shares, or a...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee